KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Treasury Shares: 2012-2025

Historic Treasury Shares for Emergent BioSolutions (EBS) over the last 13 years, with Sep 2025 value amounting to $243.5 million.

  • Emergent BioSolutions' Treasury Shares rose 6.94% to $243.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $243.5 million, marking a year-over-year increase of 6.94%. This contributed to the annual value of $227.7 million for FY2024, which is negligibly% changed negligibly from last year.
  • As of Q3 2025, Emergent BioSolutions' Treasury Shares stood at $7.9 million, which was up 17.91% from $6.7 million recorded in Q2 2025.
  • Over the past 5 years, Emergent BioSolutions' Treasury Shares peaked at $7.9 million during Q3 2025, and registered a low of $1.2 million during Q1 2021.
  • Moreover, its 3-year median value for Treasury Shares was $5.6 million (2025), whereas its average is $5.9 million.
  • Data for Emergent BioSolutions' Treasury Shares shows a peak YoY skyrocketed of 475.00% (in 2022) over the last 5 years.
  • Over the past 5 years, Emergent BioSolutions' Treasury Shares (Quarterly) stood at $152.2 million in 2021, then surged by 49.61% to $227.7 million in 2022, then remained steady at $227.7 million in 2023, then remained steady at $227.7 million in 2024, then grew by 6.94% to $243.5 million in 2025.
  • Its last three reported values are $243.5 million in Q3 2025, $234.6 million for Q2 2025, and $227.7 million during Q1 2025.